This site uses cookies to bring you the best experience. Find out more
Skip to main content


Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on if you would like to know more about any of these stories.

You can also follow us on X or LinkedIn  

Oxford Bio Therapeutics relocates UK Headquarters to strategic and cutting-edge R&D location at The Oxford Science Park

Oxford, UK and San Jose, Calif., 11 October 2023 Oxford BioTherapeutics Ltd. (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and antibody-drug conjugate (ADC)-based therapies, today announced that it has relocated its UK headquarters to The Schrodinger Building within The Oxford Science Park. The new facilities comprise state-of-the-art office and custom laboratory spaces that will support and enhance OBT’s growing... Read more

The Iversen Building

On Wednesday, the 27th of September, The Oxford Science Park was delighted to host the opening of the latest and hugely exciting addition to its portfolio: the Iversen Building. This new 88,000 sq ft NIA lab-ready facility expands the Park's total area by almost 20% and significantly increases its capacity for high-quality laboratories.  The Iversen Building is the largest and most advanced spec-built commercial science building in Oxfordshire... Read more

Sustainable Transport Month

During September, The Oxford Science Park organises various activities and campaigns to raise awareness and encourage sustainable transportation options like E-bikes, E-scooters and a Liftshare community. We’re pleased to announce that DASH, the all-inclusive E-Bike subscription service will be joining us at the Oxford Science Park on Sept 19th & 20th offering advice, free test rides and complementary health checks for your existing bike. In... Read more

BioForward is back in Oxford and bigger than ever!

BioForward is OBN (UK) Ltd's 'Roadmap for Growth' Life Sciences event, designed to provide the support, skills, know-how and industry connections required to build a commercially successful business. Now in its fifth year, BioForward is attended by leaders and decision makers of growing R&D companies across all therapy and technological areas, alongside companies who provide services that help support the sustainable growth of emerging... Read more

Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property

IP bolsters Company’s already dominant and broad position with respect to exosome therapeutics Acquisition is in line with long-term strategy to improve exosome-mediated delivery to enable novel gene therapies and gene editors OXFORD, United Kingdom, June 20, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, has purchased Codiak Biosciences engEx-AAV™ technology platform,... Read more

The Daubeny Project

Imaginative design, inspiring spaces.